• COVID-19 RESOURCES AND PROJECTS
  • License COVID-19 Innovations
  • Access Concierge
  • Emerging Startups

News about companies born out of licensing UC Berkeley intellectual property rights

5/16/23
Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit
5/15/23
PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows
5/11/23
C. Light Receives Clearance for Retinal Eye Movement Monitor, Retitrack
5/2/23
FDA Approves Fast Track Designation for Tenaya AAV-Based Gene Therapy for Heart Disease
3/21/23
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
2/10/23
ProterixBio Announces Commercial Offering of Quantitative Soluble ST2 Assay
12/20/22
Harnessing the Potential of Regenerative Stem Cell Secretomes in Age-related Disease
11/12/22
Intellia Talks 'Functional Cure' for HAE with Interim Data for 2nd CRISPR Candidate
11/8/22
Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases
11/1/22
Pittsburgh Knights Partners with Setex for eGame Thumbgrips with Gecko-inspired Anti-slip Technology
10/27/22
DOE Funds Travertine to Grow the Minerals Supply Chain and Strengthen National Security
10/19/22
Ambi Robotics Raises Funding for New Kind of Warehouse Robot
10/5/22
Valitor Raises $28M Series B Financing
10/5/22
Former Berkeley Professor and Startup Founder Carolyn Bertozzi Shares Chemistry Nobel Prize
9/29/22
GM Partners with and Invests in OneD Battery Sciences in Quest for Cheap, Energy-dense EV Batteries
9/27/22
Sanofi and Jennifer Doudna-Founded Scribe Ink $1B CRISPR Cell Therapy Deal
9/14/22
Cultured meat startup Prolific Machines unveils its ‘Henry Ford approach’ to cell growth
9/4/22
Intropic Materials Selected as Biomimicry Ray of Hope Prize Finalist 
8/23/22
Clarity Movement Co. Raises US$9.6M Series A+
8/17/22
Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease
8/4/22
Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen
8/3/22
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
7/29/22
Synthetic Bio Startup Huue Secures $14.6M Series A to Launch The World’s First Clean & Scalable Indigo Dye
7/25/22
Quantum Dot and MicroLED Pioneer Nanosys Secures Over $50 Million in Growth Capital Financing
7/15/22
The Secret Behind the Bay Area’s Most Popular Tropical Beers: GMO Yeast
7/15/22
Your Choice Raises $15M in Series A
7/1/22
Serinus Labs Recognized Among World's Top 15 Techpreneurs
6/23/22
Magnetic Insight Raises $17M in Series B
6/16/22
Travertine Raises $3M to Commercialize Carbon Capture Technology
6/9/22
ResVita Bio Receives Rare Pediatric Disease Designation for RVB-001 as a Treatment for Netherton Syndrome
5/23/22
From DNA to RNA to KaRNAteq
5/12/22
Caribou Aces its First Round of Human Data in Search of an Off-the-shelf CAR-T Breakthrough
5/10/22
Startup to Sale: How Tom McDonald Built and Sustained Mosaic Materials
5/3/22
Nanosys Quantum Dot Technology Wins Display Component of The Year Award
5/2/22
Scribe Therapeutics Expands Collaboration With Biogen to Second Target
4/27/22
CalWave and Launch Alaska Sign MOU to Advance Wave Energy Projects
4/22/22
Baker Hughes acquires Mosaic Materials
4/18/22
Lygos and Flexible Solutions International Announce Merger to Form Leading Sustainable Specialty Ingredient Company
4/11/22
Ansa Biotechnologies Closes $68M Series A Financing
4/5/22
Demetrix and Evonik Sign Supply Agreement for Cannabinoids
3/22/22
Spotlight Therapeutics Raises $36.5 Million Series B to Advance a Pipeline of Cell-Targeted In Vivo CRISPR Gene Editing Biologics
2/28/22
Intellia Therapeutics Shows Improved, Sustained Effect from In Vivo CRISPR Treatment
2/24/22
Enable Biosciences Clinical Reference Lab Accredited by the College of American Pathologists
2/16/22
Get Me (DNA) Rewrite: Intellia’s First Acquisition Expands CRISPR Toolkit
2/9/22
BioMADE Funds Pilot Project to De-risk Toxic Product Production in US Bioindustrial Manufacturing
2/3/22
Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics
2/2/22
Juvena Therapeutics Awarded CIRM Grant to Advance Myotonic Dystrophy Type 1 Therapeutic
1/25/22
DOE Awards CalWave $7.5 Million for Cutting-Edge Wave Energy Converter
1/24/22
Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test
1/22/22
Sugarlogix Announces Relaunch as NAMUH
1/13/22
Imprint Energy Launches New Generation of Ultrathin, Flexible, Printed Batteries
1/12/22
Intellia Adds Cardiomyopathy Patients to Existing Early-stage ATTR Study
1/10/22
6 Beer Industry Trends to Watch in 2022
1/10/22
Mercator MedSystems Receives NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy
1/10/22
FDA Fast Track Designation Granted to 4D Molecular Therapeutics 4D-125 for the Treatment of X-linked Retinitis Pigmentosa
1/10/22
Microgrid Labs, Provider of Electrification and Microgrid Software, Raises $2.25M 
1/10/22
Bayer to Pay CRISPR-focused Mammoth Biosciences $40 Million for Gene Editing Research
1/3/22
Amyris and ImmunityBio Complete Joint Venture for Next Generation COVID-19 RNA Vaccine
12/21/21
Microgrid Labs Nominated for 2022 Edison Awards
12/16/21
Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding
12/14/21
Catalyze Invests In and Partners With Microgrid Labs
11/29/21
Lucira's at Home Molecular Tests Can Detect Omicron SARS CoV-2 Variant of Concern
11/24/21
Water Harvesting Technology in Smithsonian FUTURES exhibit
11/23/21
Jacobs Enters into Strategic Partnership with Microgrid Labs
11/22/21
Intellia Therapeutics Expands Phase 1 Study to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy
11/11/21
First Magnetic Particle Imaging (MPI) Scanner Installed in Europe, at Stockholm Karolinska Institutet
11/8/21
Amyris Announces Joint Venture Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
11/4/21
Scribe Therapeutics Wins 2021 Pantheon Rising Star Award
11/2/21
Ottobock Acquires Exoskeleton Specialist suitX
10/14/21
OneD to Build Pilot Silicon-Graphite-Anode Plant
10/13/21
Intellia Therapeutics Collaborates with SparingVision to Develop Ocular Therapies
10/12/21
Lucira Health COVID-19 Test Approved for Sale in Singapore
10/7/21
Self-Destructing Plastic Wins Top Prize in Create the Future Contest
10/6/21
Intellia Phase 1/2 Clinical Trial Authorized for Hereditary Angioedema Treatment
10/6/21
CalWave Commissions Open-water Wave Energy Pilot
10/5/21
Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients
9/28/21
Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline
9/23/21
GenEdit Closes $26 Million in Series A Financing
9/21/21
Organos Awarded $1.5M NIH SBIR Grant
9/14/21
Ambi Robotics Announces $26 Million Series A Funding Led By Tiger Global
9/9/21
Research Shows Racial and Ethnic Disparities in Bay Area Air Pollution
9/9/21
Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech to Unicorn Status
9/8/21
Contest Challenges Inventors to Harness Wave Power to Desalinate Seawater
9/8/21
Breakthrough "Air Stable" Quantum Dot Component Enters Mass Production
8/27/21
14 Best Berkeley Medical Device Startups Revolutionizing Healthcare
8/19/21
Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes
8/13/21
U.S. Airforce Tests SuitX Exoskeletons to Prevent Fatigue-related Accidents
8/12/21
Iaterion, Inc. Awarded NIH Grant for Nuclear Receptor Coligand Platform
8/12/21
AngioDynamics Receives FDA Approval for PRESERVE Study
8/11/21
Magnetic Insight Installs Localized Magnetic Theranostic System at Johns Hopkins University
8/11/21
FDA-approved Trial Evaluates AngioDynamics’ NanoKnife for Prostate Tissue Ablation
7/30/21
Tenaya Therapeutics Prices $180M IPO for Targeted Therapies
7/28/21
Study Reveals Gene Involved in Stem Rust Resistance in Wheat
7/26/21
StreetLight Data Partnership Aims to Help Expand EV Chargers
7/23/21
Caribou Raises $304M in One of Gene Editing's Most Lucrative IPOs
7/21/21
Berkeley startup aims to be a game changer in autoimmune disease therapy
7/19/21
With Focus on the 'Undruggable,' Biotech Raises $88.5M Series B from IPO-minded Investors
7/19/21
Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline
7/14/21
Enable Biosciences Supports California Department of Public Health's CalScope Program to Survey COVID-19 Antibodies from Infection and Vaccination
7/13/21
Tenaya Therapeutics Preclinical Research Supports Product Candidate for Heart Disease Indications
7/12/21
Clinical Trial of CRISPR-Edited Cell Therapy Launched for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
7/9/21
Heart disease biotech Tenaya Therapeutics files for a $100 million IPO
7/3/21
Cannabinoids Are the Next Big Thing in the Pot Industry, But Who Can Mass-Produce It?
7/2/21
Caribou Biosciences Files for $100M IPO
7/1/21
Amyris Completes First Major License For RNA COVID Vaccine Advancing Technology To Human Trials
6/29/21
Enable Biosciences Supports California Department of Public Health CalScope Program to Survey COVID-19 Antibodies from Infection and Vaccination
6/28/21
In Major CRISPR Milestone, Intellia Successfully Edits Genes Inside the Body
6/10/21
A World First in Imaging Technology, Developed by Magnetic Insight
Join the IPIRA Mailing List

 

 
 
 
 

 

Accessibility | Nondiscrimination | Privacy